CV Lattes
Universidade de São Paulo (USP). Faculdade de Ciências Farmacêuticas (FCF) (Institutional affiliation from the last research proposal) Birthplace: Brazil
PhD obtained at the Pharmacy (Pathophysiology and Toxicology) postgraduate program at the School of Pharmaceutical Sciences in the University of Sao Paulo (FCF-USP), with FAPESP grant, started in Dec/2016. Visiting PhD student at Karolinska Institutet, Sweden, under the supervision of prof. Volker M. Lauschke, from 2019 to 2020. Graduated in Pharmacy-Biochemistry at the University of Sao Paulo (2009-2015), with training in Pharmacovigilance at the School of Pharmaceutical Sciences of the Sao Paulo State University Julio de Mesquita Filho (FCF-UNESP) from Mar/2016 to Aug/2016. I have concluded two research projects: the first in Molecular Biology under the supervision of Prof. Aline Maria da Silva, Ph.D. (IQ-USP) (2010-2011) and the second in Pharmacovigilance under the supervision of Prof. Nicolina Silvana Romano Lieber (FSP-USP) (2014-2015). I also studied at the Universidad Autónoma de Madrid (Madrid, 2012) with a scholarship provided by Santander bank. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Familial Hypercholesterolemia (FH) is a primary dyslipidemia with frequent monogenic inheritance resulting from functional mutations in the Low Density Lipoprotein Receptor (LDLR), apolipoprotein B (APOB) and Proprotein convertase subtilisin/kexin type 9 (PCSK9) genes, which codify proteins that regulate cholesterol homeostasis. The first-line treatment consists of the use of statins, suc…
Chart review using triggers has been considered one of the most efficient methods for adverse drug events (ADE) detection. Recently, a list of pediatric-specific triggers has been developed. However, there still are few studies using this tool, especially with children hospitalized in Pediatric Intensive Care Unit (PICU), which are more likely to have ADE. Therefore, it is necessary to st…
Familial hypercholesterolemia (FH) is a primary dyslipidemia resulting from functional mutations in cholesterol homeostasis genes. Statins are the first-line treatment, but the response is highly variable among individuals. Pharmacogenetic scores have been developed to predict this variability, but none is specific to the Brazilian FH population. Also, the impact of variants found on prod…
| 2 / 2 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 3 / 3 | All Scholarships |
| Associated processes | |